Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 649303
                    [Title] => Chile, NZ to use GSK pneumococcal vaccine
                    [Summary] => 
GlaxoSmithKline’s (GSK) pneumococcal vaccine has been chosen to be incorporated in the national immunization programs for newborns and infants in Chile and New Zealand.
                    [DatePublished] => 2011-01-20 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

CHILE AND NEW ZEALAND

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 649303
                    [Title] => Chile, NZ to use GSK pneumococcal vaccine
                    [Summary] => 
GlaxoSmithKline’s (GSK) pneumococcal vaccine has been chosen to be incorporated in the national immunization programs for newborns and infants in Chile and New Zealand.
                    [DatePublished] => 2011-01-20 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Chile, NZ to use GSK pneumococcal vaccine

January 20, 2011 - 12:00am

GlaxoSmithKline’s (GSK) pneumococcal vaccine has been chosen to be incorporated in the national immunization programs for newborns and infants in Chile and New Zealand.

Science and Environment